The Recall Desk

State

Washington product recalls

73,892 recalls have nationwide distribution and so reach Washington. 8,539 additional recalls listed Washington specifically in their distribution scope.

What the numbers show

Total
8,539
Critical
865
Severe
2,407
Most recent
2026-11-11

Of the 8,539 recalls naming Washington we have scored against our rubric, 865 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,407 (28%) are Severe.

These figures cover only the 8,539 recalls whose distribution notice names Washington specifically. The 73,892 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

63326–63350 of 82431

  • SevereFDA (Drugs)·D-0216-2015·2014-11-12

    FDA Recalls Papaverine Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Papaverine/Phentolamine/Prostaglandin injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.16mg/0.57mg/19.45mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Food)·F-0099-2015·2014-11-12

    Dancing Star Recalls Carob Supergreens Chunks of Energy Due to Salmonella Risk

    Dancing Star LLC is recalling specific lots of Carob Supergreens Chunks of Energy and Rave Bites Carob Supergreens because they may be contaminated with Salmonella.

    Product
    Carob Supergreens Chunks of Energy (10# UPC 7-69270-10009-7); also, Carob Supergreens Chunks of Energy and Rave BItes Brand Carob Supergreens (7 oz UPC 7-69270-70008-8).
    Category
    Food
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0205-2015·2014-11-12

    FDA Recalls Injectable Methycobalamin Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling injectable Methycobalamin vials due to quality control issues that present a potential risk to sterility assurance.

    Product
    METHYCOBALAMIN, preservative, 1mg/mL, injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0195-2015·2014-11-12

    FDA Recalls Injectable Glutathione Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling injectable glutathione vials because quality control issues observed during an FDA inspection present a potential risk to sterility assurance.

    Product
    GLUTATHIONE with preservative, 100mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0196-2015·2014-11-12

    FDA Recalls Injectable Glutathione Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling injectable glutathione vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    GLUTATHIONE, 100 mg/mL, injectable, 100 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0228-2015·2014-11-12

    FDA Recalls Vitamin B Complex Injectable Due to Sterility Concerns

    Oregon Compounding Centers is recalling Vitamin B Complex injectable vials due to quality control issues affecting sterility assurance.

    Product
    VITAMIN B COMPLEX (PRES) injectable, 100mg, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0204-2015·2014-11-12

    Recall of Injectable Methycobalamin Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling specific lots of injectable Methycobalamin due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    METHYCOBALAMIN, preservative free, 20mg/mL, injectable, 0.3 mL or 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0188-2015·2014-11-12

    FDA Recalls Epinephrine Vials Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Epinephrine 1:1000 injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    EPINEPHRINE/WATER, preservative free 1:1000, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0203-2015·2014-11-12

    FDA Recalls Methycobalamin Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling specific lots of Methycobalamin injectable due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    METHYCOBALAMIN, preservative free, 1mg/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0180-2015·2014-11-12

    Creative Compounds Recalls Ceftazidime Syringes Due to Sterility Concerns

    Oregon Compounding Centers is recalling Ceftazidime syringes because quality control issues observed during an FDA inspection may compromise sterility assurance.

    Product
    CEFTAZIDIME, 2.25mg/0.1mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0178-2015·2014-11-12

    FDA Recalls Bevacizumab/Dexamethasone Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Bevacizumab/Dexamethasone injectable syringes due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    BEVACIZUMAB/DEXAMETHASONE, 1.25/0.5 mL, Injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0211-2015·2014-11-12

    FDA Recalls Papaverine HCL Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Papaverine HCL injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    PAPAVERINE HCL, with preservative, 30 mg/mL, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0206-2015·2014-11-12

    Mitomycin Injectable Vials Recalled for Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Mitomycin injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    MITOMYCIN, 0.2mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0190-2015·2014-11-12

    FDA Recalls Ganciclovir Syringes Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling 40 syringes of Ganciclovir due to quality control issues affecting sterility assurance found during an FDA inspection.

    Product
    GANCICLOVIR -preservative free, 2mg/0.1mL, injectable, 0.1 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0184-2015·2014-11-12

    FDA Recalls Copper Sulfate Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Copper Sulfate injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    COPPER (SULF), 0.4 mg/mL, injectable, 20 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0198-2015·2014-11-12

    FDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Hydroxocobalamin (B12) injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    HYDROXOCOBALAMIN-preservative free (B12), 1mg/mL, injectable, 2 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0226-2015·2014-11-12

    FDA Recalls Trience Injectable Syringes Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Trience 8mg/2.0mL injectable syringes due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    TRIESENCE, 8mg/2.0mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0209-2015·2014-11-12

    FDA Recalls Injectable Papaverine HCL/Phentolamine/Prostaglandin Due to Sterility Concerns

    Oregon Compounding Centers is recalling specific lots of injectable Papaverine HCL/Phentolamine/Prostaglandin due to quality control issues affecting sterility assurance.

    Product
    PAPAV HCL/PHENTOL/PROSTAGL, 12mg/1mg/10mcg, injectable, 1.25 mL glass vial or 1.7 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Food)·F-0462-2015·2014-11-12

    Saba Shark Cartilage Complex Recalled for Potential Salmonella Presence

    AMS Health Sciences is recalling Saba Shark Cartilage Complex dietary supplements due to the potential presence of Salmonella.

    Product
    Saba Shark Cartilage Complex Dietary Supplement, 500 mg, 60 Capsules, Distributed by Saba 711 NE 39th Street, Oklahoma City, OK 73105
    Category
    Food
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0181-2015·2014-11-12

    Recall of Chorionic Gonadotropin Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling 145 vials of Chorionic Gonadotropin due to quality control issues affecting sterility assurance.

    Product
    CHORIONIC GONADOTROPIN, 4000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0185-2015·2014-11-12

    FDA Recalls Dexamethasone Injectable Vials Due to Sterility Concerns

    Oregon Compounding Centers is recalling Dexamethasone injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    DEXAMETHASONE (AS SOD PHOS), 24 mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0217-2015·2014-11-12

    FDA Recalls Compounded Injectable Drug Due to Sterility Concerns

    Oregon Compounding Centers is recalling Papaverine/Phentolamine/Prostaglandin injectable vials due to quality control issues affecting sterility assurance.

    Product
    PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.44mg/0.64mg/5.8mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0201-2015·2014-11-12

    FDA Recalls Lidoaine HCL Solution Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Lidoaine HCL solution for irrigation due to quality control issues affecting sterility assurance.

    Product
    LIDOCAINE HCL (REPKG-STERILE), 4%, solution for irrigation, 5 mL, 6 mL, and 7 mL plastic dropper bottle, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0214-2015·2014-11-12

    FDA Recalls Papaverine Injectable Due to Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Papaverine HCL/Phentolamine/Prostaglandin injectable vials due to quality control issues affecting sterility assurance.

    Product
    PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN, 27.7mg/0.45mg/45.45mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0173-2015·2014-11-12

    Alprostadil Injectable Recalled for Sterility Assurance Concerns

    Oregon Compounding Centers is recalling Alprostadil injectable vials due to quality control issues affecting sterility assurance identified during an FDA inspection.

    Product
    ALPROSTADIL, 10 mcg/mL, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070.
    Category
    Drug
    Distribution
    2 states